Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine
L Dias, R Soares-dos-Reis, J Meira, D Ferrão… - Journal of Stroke and …, 2021 - Elsevier
The development of SARS-CoV-2 vaccines has raised several concerns regarding venous
thromboembolism, namely cerebral venous thrombosis. Although cerebral venous
thrombosis has been reported after administration of a viral vector vaccine, due to a possible
auto-immune mechanism inducing thrombocytopenia, the same has not happened in mRNA
vaccines. We report two cases of cerebral venous thrombosis, shortly after administration of
mRNA vaccine. In both patients, there was no evidence of thrombocytopenia or antiplatelet …
thromboembolism, namely cerebral venous thrombosis. Although cerebral venous
thrombosis has been reported after administration of a viral vector vaccine, due to a possible
auto-immune mechanism inducing thrombocytopenia, the same has not happened in mRNA
vaccines. We report two cases of cerebral venous thrombosis, shortly after administration of
mRNA vaccine. In both patients, there was no evidence of thrombocytopenia or antiplatelet …